Medicine and Dentistry
Patient
100%
Acute Coronary Syndrome
61%
Combination Therapy
60%
Inpatient
55%
Atrial Fibrillation
42%
Percutaneous Coronary Intervention
34%
Bleeding
33%
Meta-Analysis
27%
Myocardial Infarction
25%
Edoxaban
25%
Antiplatelet
24%
Coronary Artery Disease
22%
Therapeutic Procedure
22%
Antithrombotic Therapy
22%
Thrombosis
22%
Low Density Lipoprotein Cholesterol
19%
Acetylsalicylic Acid
18%
Antithrombotic
18%
Follow up
18%
Gene
17%
Cardiovascular Disease
17%
Randomized Controlled Trial
16%
Cardiovascular System
16%
Odds Ratio
16%
Prothrombin G20210A
15%
Mortality
13%
Cardiology
13%
Percutaneous Endoscopic Gastrostomy
13%
Anticoagulation
12%
Apoplexy
12%
Coronary Stenting
12%
Platelet
12%
Heart Muscle Ischemia
11%
Diseases
11%
Woman
11%
Age
11%
Interleukin 6
11%
Anticoagulant Therapy
10%
ST Elevation
10%
Diagnosis
10%
Coronary Artery Bypass Graft
10%
Plasminogen Activator Inhibitor-1
10%
Association
9%
Monitoring
9%
Primary Prevention
9%
Genotype
9%
Plaque
9%
Cardiovascular Risk
8%
Ischemic Heart Disease
8%
Revascularization
8%
Pharmacology, Toxicology and Pharmaceutical Science
Atrial Fibrillation
32%
Bleeding
28%
Acute Coronary Syndrome
27%
Edoxaban
25%
Anticoagulant Agent
24%
Antithrombotic Therapy
21%
Low Density Lipoprotein Cholesterol
15%
Acetylsalicylic Acid
12%
Thrombosis
11%
Ciclonicate
11%
Direct Oral Anticoagulant
10%
Placebo
10%
Heart Infarction
10%
Heparin
8%
Mortality
8%
Polymer
8%
Malignant Neoplasm
8%
Cardiovascular Risk
7%
Randomized Controlled Trial
7%
Erythropoietin
7%
Coronary Artery Disease
6%
ST Segment Elevation Myocardial Infarction
6%
Thromboembolism
6%
Obesity
6%
Monotherapy
6%
Death
5%
Drug
5%
Complication
5%
Clopidogrel
5%
Stent
5%
Ischemic Heart Disease
5%
Low Molecular Weight Heparin
5%
Nursing and Health Professions
Patient
33%
Atrial Fibrillation
25%
Inpatient
23%
Edoxaban
19%
Acute Coronary Syndrome
16%
Interleukin 6
13%
Percutaneous Coronary Intervention
12%
Alka-Seltzer
10%
Ciclonicate
10%
Anticoagulation
9%
Meta Analysis
9%
Nitric Oxide
9%
Time
8%
Combination Therapy
8%
Inflammation
8%
Pathophysiology
8%
Obesity Management
8%
Percutaneous Endoscopic Gastrostomy
7%
Hospital
7%
Fibrinogen
6%
Drug Eluting Stent
6%
Procedures
5%
Man
5%
Marker
5%
Cardiovascular Disease
5%
Low Density Lipoprotein Cholesterol
5%
Low Density Lipoprotein Cholesterol Level
5%
Dual Antiplatelet Therapy
5%
